According to NBC 10 in Providence, the White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the United States as it projects COVID-19 infections will continue to spread over the summer travel season. The nation's first federally backed test-to-treat site is opening today in Rhode Island, providing patients with immediate access to the drug once they test positive with more federally supported sites set to open in Massachusetts and New York City soon. Federal regulators have also sent clearer guidance to physicians to help them determine how to manage paxlovid's interactions with other drugs, with an eye toward helping prescribers find ways to get the life-saving medication to more patients. The U.S. has ordered 20 million courses of Paxlovid from the drugmaker Pfizer, and the country risks running out this winter if the drug continues to be used widely.